Janja Ocvirk

1.9k citations
69 papers · 1.3k indexed · 1 hit paper · h-index 17

Impact in

  • Oncology top 2%
    • Colorectal Cancer Treatments and Studies
    • Cancer Treatment and Pharmacology
    • Colorectal Cancer Surgical Treatments
  • Hepatology top 5%
    • Hepatocellular Carcinoma Treatment and Prognosis

Papers in

    • Colorectal Cancer Treatments and Studies 39
    • Cancer Treatment and Pharmacology 18
    • Colorectal Cancer Surgical Treatments 10

Janja Ocvirk

60 papers receiving 1.3k citations

Hit Papers

Bevacizumab plus capecitabine versus capecitabine alone in elderly patients with previously untreated metastatic colorectal cancer (AVEX): an open-label, randomised phase 3 trial 2013 · 438 citations
4382013202620172021100200300400

Peers

Janja Ocvirk
Comparison fields: 5 of 88
  • Oncology 1.0k
  • Hepatology 226
  • Pulmonary and Respiratory Medicine 376
  • Pathology and Forensic Medicine 179
  • Dermatology 87
Replace Nobuyuki Mizunuma with:
Nobuyuki Mizunuma Japan
Eugenio Marcuello Spain
Karen Rittweger United States
H. Kröning Germany
Isabel Chirivella Spain
K. Syrigos Greece
G.J. Creemers Netherlands
B. Massidda Italy
May Mabro France
Tatsu Shimoyama Japan
Janja Ocvirk relative to Nobuyuki Mizunuma Japan Nobuyuki Mizunuma's profile →
Citations per field
00.5×1.5×
Nobuyuki Mizunuma · 1×
Citations per year

Countries citing papers authored by Janja Ocvirk

Since Specialization
Citations

This map shows the geographic impact of Janja Ocvirk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Janja Ocvirk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Janja Ocvirk more than expected).

Fields of papers citing papers by Janja Ocvirk

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Janja Ocvirk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Janja Ocvirk. The network helps show where Janja Ocvirk may publish in the future.

Co-authors

The 25 scholars most cited alongside Janja Ocvirk, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Janja Ocvirk Line = papers co-authored together Janja Ocvirk links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20244
2 20241
3 20234
4 202315
5 20231
6 20216
7 202011
8 20194
9 20194
10 20192
11 20190
12 201821
13 20184
14 20189
15 20154
16 201420
17 20115
18
Nevroendokrini tumorji prebavil
20110
19 201092
20 200940

About Janja Ocvirk

Janja Ocvirk is a scholar working on Oncology, Dermatology, Hepatology, Genetics and Pulmonary and Respiratory Medicine, having authored 69 papers that have together received 1.3k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (39 papers), Cancer Treatment and Pharmacology (18 papers), Colorectal Cancer Surgical Treatments (10 papers), Colorectal and Anal Carcinomas (10 papers), Gastric Cancer Management and Outcomes (10 papers), Hepatocellular Carcinoma Treatment and Prognosis (7 papers), Genetic factors in colorectal cancer (7 papers) and Melanoma and MAPK Pathways (6 papers). The work is most often cited by research in Oncology (1.0k citations), Hepatology (226 citations), Pulmonary and Respiratory Medicine (376 citations), Pathology and Forensic Medicine (179 citations) and Dermatology (87 citations). Janja Ocvirk has collaborated with scholars based in Slovenia, Germany and United States. Frequent co-authors include Martina Reberšek, David Cunningham, István Láng, Daniel Waterkamp, Mark Saunders, Derek J. Jonker, Stuart Osborne, Vito Lorusso, Eugenio Marcuello and Dong Bok Shin. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Radiology and Oncology, Biomedicines and BMC Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026